Padraig E O'Suilleabhain

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi Proprioception in Parkinson's disease is acutely depressed by dopaminergic medications
    P O'Suilleabhain
    Department of Neurology, University of Texas, Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9036, USA
    J Neurol Neurosurg Psychiatry 71:607-10. 2001
  2. ncbi Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations
    Padraig E O'Suilleabhain
    Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Arch Neurol 61:865-8. 2004
  3. ncbi Clinical course in Parkinson's disease with elevated homocysteine
    Padraig E O'Suilleabhain
    Department of Neurology, Southwestern Medical Center at Dallas, University of Texas, 5323 Harry Hines Boulevard, Dallas, TX 75390 9036, USA
    Parkinsonism Relat Disord 12:103-7. 2006
  4. ncbi Movement disorders after head injury: diagnosis and management
    Padraig O'Suilleabhain
    Department of Neurology, University of Texas Southwestern Medical School, Dallas, 75390, USA
    J Head Trauma Rehabil 19:305-13. 2004
  5. ncbi Tremor response to polarity, voltage, pulsewidth and frequency of thalamic stimulation
    Padraig E O'Suilleabhain
    Department of Neurology, UT Southwestern Medical School, Dallas, TX, USA
    Neurology 60:786-90. 2003
  6. ncbi Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease
    Padraig E O'Suilleabhain
    Clinical Center for Movement Disorders, Department of Neurology, University of Texas Southwestern Medical School, Dallas, TX, USA
    Arch Neurol 59:986-9. 2002
  7. ncbi Randomized trial comparing primidone initiation schedules for treating essential tremor
    Padraig O'Suilleabhain
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Mov Disord 17:382-6. 2002
  8. ncbi Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease
    Padraig E O'Suilleabhain
    Department of Neurology, University of Texas Southwestern Medical School, Dallas, Texas, USA
    Mov Disord 19:1403-8. 2004
  9. ncbi A stereotactic near-infrared probe for localization during functional neurosurgical procedures: further experience
    Cole A Giller
    Baylor Radiosurgery Center, Baylor University Medical Center, Dallas, TX 75246, USA
    J Neurosurg 110:263-73. 2009
  10. ncbi Autonomic dysfunction in Parkinson's disease
    Richard B Dewey
    Department of Neurology, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Neurol Clin 22:S127-39. 2004

Detail Information

Publications21

  1. ncbi Proprioception in Parkinson's disease is acutely depressed by dopaminergic medications
    P O'Suilleabhain
    Department of Neurology, University of Texas, Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9036, USA
    J Neurol Neurosurg Psychiatry 71:607-10. 2001
    ..This study tested for effects on proprioception of dopaminergic drugs, and for associations between such effects and drug induced dyskinesias...
  2. ncbi Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations
    Padraig E O'Suilleabhain
    Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Arch Neurol 61:865-8. 2004
    ..An Hcy elevation is prevalent in patients with Parkinson disease (PD) in part because levodopa metabolism produces Hcy. The clinical relevance of an elevated Hcy level in patients with PD is unknown...
  3. ncbi Clinical course in Parkinson's disease with elevated homocysteine
    Padraig E O'Suilleabhain
    Department of Neurology, Southwestern Medical Center at Dallas, University of Texas, 5323 Harry Hines Boulevard, Dallas, TX 75390 9036, USA
    Parkinsonism Relat Disord 12:103-7. 2006
    ..03). We conclude that hyperhomocysteinemia does not predict significantly worse progression over 2 years in early PD. The data raised the possibility of higher mortality, but the number of deaths was small...
  4. ncbi Movement disorders after head injury: diagnosis and management
    Padraig O'Suilleabhain
    Department of Neurology, University of Texas Southwestern Medical School, Dallas, 75390, USA
    J Head Trauma Rehabil 19:305-13. 2004
    ..Reversible causes such as medications or metabolic derangements are occasionally identifiable. Some of these adventitious movements can be improved using neuroactive drugs, botulinum toxin injections, or stereotactic brain surgery...
  5. ncbi Tremor response to polarity, voltage, pulsewidth and frequency of thalamic stimulation
    Padraig E O'Suilleabhain
    Department of Neurology, UT Southwestern Medical School, Dallas, TX, USA
    Neurology 60:786-90. 2003
    ..The relative impacts of these programmable variables have not previously been quantified...
  6. ncbi Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease
    Padraig E O'Suilleabhain
    Clinical Center for Movement Disorders, Department of Neurology, University of Texas Southwestern Medical School, Dallas, TX, USA
    Arch Neurol 59:986-9. 2002
    ..Excessive daytime somnolence is a common report among patients who have Parkinson disease (PD). The relative contributions of disease severity and of the various dopaminergic drugs are unclear...
  7. ncbi Randomized trial comparing primidone initiation schedules for treating essential tremor
    Padraig O'Suilleabhain
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Mov Disord 17:382-6. 2002
    ..If anything, compliance tended to be worse when compared with the tablet formulation, though the study was under-powered to reject the null hypothesis of equivalence...
  8. ncbi Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease
    Padraig E O'Suilleabhain
    Department of Neurology, University of Texas Southwestern Medical School, Dallas, Texas, USA
    Mov Disord 19:1403-8. 2004
    ..Levodopa elevates tHcy and lowers vitamin B12 concentration to modest degrees. The clinical implications, if any, have not yet been determined...
  9. ncbi A stereotactic near-infrared probe for localization during functional neurosurgical procedures: further experience
    Cole A Giller
    Baylor Radiosurgery Center, Baylor University Medical Center, Dallas, TX 75246, USA
    J Neurosurg 110:263-73. 2009
    ..In the current study they extend and further validate this technology...
  10. ncbi Autonomic dysfunction in Parkinson's disease
    Richard B Dewey
    Department of Neurology, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Neurol Clin 22:S127-39. 2004
  11. ncbi Medical management of motor fluctuations
    Richard B Dewey
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9036, USA
    Neurol Clin 26:S15-27, v. 2008
    ..This article briefly reviews the medical options for managing motor fluctuations that are in common use in the United States or that are expected to be available soon...
  12. ncbi An unusual variant of the dorsal midbrain syndrome in MS: clinical characteristics and pathophysiologic mechanisms
    Elliot M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Mult Scler 10:322-5. 2004
    ..We consider the pathophysiologic mechanisms responsible for our observations and review important details of the dorsal midbrain ocular motor circuitry...
  13. ncbi Ventralis intermedius thalamotomy can succeed when ventralis intermedius thalamic stimulation fails: report of 2 cases for tremor
    Cole A Giller
    Department of Neurological Surgery and Neurology, University of Texas Southwestern Medical Center, Dallas 75235, USA
    Stereotact Funct Neurosurg 79:51-6. 2002
    ..These cases illustrate that the effects of deep brain stimulation might not be those of simple inhibition, and that thalamotomy should be considered when deep brain stimulation does not succeed...
  14. ncbi A new measure of dysconjugacy in INO: the first-pass amplitude
    Elliot M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
    J Neurol Sci 210:65-71. 2003
    ....
  15. ncbi Attitudes and performance of third- vs fourth-year neurology clerkship students
    Richard B Dewey
    Department of Neurology, University of Texas Southwestern Medical School, Dallas, TX 75390 9036, USA
    Arch Neurol 67:548-51. 2010
    ..To compare student performance, attitudes, and career plans based on whether the neurology clerkship was taken in the third or fourth year...
  16. ncbi Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease
    Richard B Dewey
    Department of Neurology and Division of Cardiology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9036, USA
    Arch Neurol 64:377-80. 2007
    ....
  17. ncbi Management of motor complications in Parkinson's disease
    Richard B Dewey
    Department of Neurology, UT Southwestern Medical Center, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX 75390-9036, USA
    Neurology 62:S3-7. 2004
    ..The unmet need for treatment of "off" episodes suggests the potential utility of an agent such as apomorphine injectable, which can reliably trigger an "on" response within 10-15 minutes of injection...
  18. ncbi Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease
    Rodger J Elble
    Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA
    Mov Disord 25:1082-6. 2010
    ..We found the investigators' level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment...
  19. ncbi Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists
    Asha Singh
    Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390 9036, USA
    J Clin Neurosci 14:1178-81. 2007
    ..Follow-up of the pathologic gamblers 1 year after intervention, which was cessation of the dopamine agonist in most cases, found ongoing but controlled gambling in five and complete cessation within 4 months in the remainder...
  20. ncbi Adult polyglucosan body disease associated with lewy bodies and tremor
    Jaya R Trivedi
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, 75390, USA
    Arch Neurol 60:764-6. 2003
    ..Although polyglucosan bodies were seen in substantia nigra, it is most likely that our patient had coexisting Parkinson disease...
  21. ncbi Distinguishing neurogenic from non-neurogenic detrusor overactivity: a urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson's disease
    Gina A Defreitas
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
    Urology 62:651-5. 2003
    ..DO owing to Parkinson's disease occurs earlier during filling compared with non-neurogenic DO, especially in women. The duration and severity of Parkinson's disease are not predictive of the nature or severity of UDS abnormalities...